Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?

Since the beginning of the SARS-CoV-2(severe acute respiratory syndrome-coronavirus-2) pandemic, a race to develop a vaccine has been initiated, considering the massive and rather significant economic and healthcare hits that this virus has caused. The pathophysiology occurring following COVID-19(co...

Descripción completa

Detalles Bibliográficos
Autores principales: Elgohary, Sawsan, Elkhodiry, Aya A., Amin, Nada S., Stein, Ulrike, El Tayebi, Hend M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912962/
https://www.ncbi.nlm.nih.gov/pubmed/33540625
http://dx.doi.org/10.3390/cells10020302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912962/
https://www.ncbi.nlm.nih.gov/pubmed/33540625
http://dx.doi.org/10.3390/cells10020302

Ejemplares similares